Last updated: 11/07/2018 10:34:14
Japanese smoker survey evaluating the prevalence of COPD in primary care patients.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Japanese smoker survey evaluating the prevalence of COPD in primary care patients.
Trial description: Investigating the prevalence of COPD and establishing evidence on an easy methodology for COPD screening
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Prevalence of COPD in subjects with smoking history in primary care
Timeframe: Study visit
Secondary outcomes:
Usefulness of COPD assessment test as a screening tool for COPD
Timeframe: Study visit
Interventions:
Not applicable
Enrollment:
2000
Primary completion date:
Not applicable
Observational study model:
Case-Only
Time perspective:
Prospective
Clinical publications:
Nakano Y, Nagai A, Mishima M, Yoshimoto D, Hagan G.Undiagnosed COPD in Japanese patients, aged over 40 with history of smoking and repeated chest infections in primary care.Nihon Ishikai Zasshi.2013;142(5):169-174
Yasutaka Nakano, Atsushi Nagai, Michiaki Mishima, Daisuke Yoshimoto, Gerald Hagan. Undiagnosed COPD in Japanese patients, aged over 40 with history of smoking and repeated chest infections in primary care.. Nihon Ishikai Zasshi. 2013;142(5):169-174.
Yoshimoto D, Nakano Y, Onishi K, Hagan G, Jones P.The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.Int J Chron Obstruct Pulmon Dis.2014;9:1357-63
Medical condition
Pulmonary Disease, Chronic Obstructive
Product
fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
Collaborators
Not applicable
Study date(s)
February 2012 to April 2012
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
40+ years
Accepts healthy volunteers
yes
- Males and females >40years of age
- Ex smokers or current smokers with >10 pack year smoking history
- Any diagnosed respiratory disease except for asthma (eg. bronchiectasis, tuberculosis, pulmonary fibrosis COPD diagnosed by spirometry, chest x-ray or CT scan)
- Acute respiratory event 4 weeks prior to screening
Inclusion and exclusion criteria
Inclusion criteria:
- Males and females >40years of age
- Ex smokers or current smokers with >10 pack year smoking history
- Recurrent episode of chest infection (>2) in last 2 years
Exclusion criteria:
- Any diagnosed respiratory disease except for asthma (eg. bronchiectasis, tuberculosis, pulmonary fibrosis COPD diagnosed by spirometry, chest x-ray or CT scan)
- Acute respiratory event 4 weeks prior to screening
- Received any bronchodilator within 24 hours of sprometry test
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
Protocol
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2012-02-04
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website